Aviva PLC Royalty Pharma PLC Transaction History

Aviva PLC

$52.8 Billion
Q3 2025

A detailed history of Aviva PLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Aviva PLC holds 298,333 shares of RPRX stock, worth $11.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

298,333

Previous 280,579 6.33%

Holding current value

$11.7 Million

Previous $10.1 Million 4.12%

% of portfolio

0.02%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$34.9 - $37.91 $619,614 - $673,054	17,754 Added 6.33%	298,333 $10.5 Million
Q2 2025 Aug 07, 2025	BUY	$30.85 - $36.14 $536,080 - $628,004	17,377 Added 6.6%	280,579 $10.1 Million
Q1 2025 May 15, 2025	BUY	$25.75 - $33.86 $878,924 - $1.16 Million	34,133 Added 14.9%	263,202 $8.19 Million
Q4 2024 Feb 13, 2025	BUY	$24.28 - $28.39 $5.22 Million - $6.1 Million	214,946 Added 1521.96%	229,069 $5.84 Million
Q3 2024 Nov 14, 2024	SELL	$25.63 - $29.27 $1,230 - $1,404	-48 Reduced 0.34%	14,123 $399,000

Q1 2024 May 14, 2024	BUY	$27.46 - $31.33 $4,860 - $5,545	177 Added 1.26%	14,171 $430,000
Q3 2023 Nov 13, 2023	SELL	$26.26 - $31.38 $1,391 - $1,663	-53 Reduced 0.38%	13,994 $379,000
Q2 2023 Aug 10, 2023	SELL	$29.6 - $36.56 $147,496 - $182,178	-4,983 Reduced 26.18%	14,047 $431,000
Q1 2023 May 12, 2023	SELL	$32.77 - $39.4 $1.01 Million - $1.22 Million	-30,939 Reduced 61.92%	19,030 $685,000
Q4 2022 Feb 09, 2023	SELL	$39.17 - $44.04 $41,050 - $46,153	-1,048 Reduced 2.05%	49,969 $1.98 Million
Q3 2022 Nov 14, 2022	SELL	$39.88 - $44.65 $961,466 - $1.08 Million	-24,109 Reduced 32.09%	51,017 $2.05 Million
Q2 2022 Aug 04, 2022	SELL	$37.53 - $44.22 $308,609 - $363,621	-8,223 Reduced 9.87%	75,126 $3.16 Million
Q1 2022 May 13, 2022	BUY	$37.46 - $42.44 $1.23 Million - $1.4 Million	32,894 Added 65.19%	83,349 $3.25 Million
Q4 2021 Feb 10, 2022	SELL	$35.17 - $42.48 $174,161 - $210,360	-4,952 Reduced 8.94%	50,455 $2.01 Million
Q3 2021 Nov 12, 2021	SELL	$36.14 - $42.24 $1.75 Million - $2.05 Million	-48,472 Reduced 46.66%	55,407 $2 Million
Q2 2021 Aug 10, 2021	BUY	$39.85 - $46.63 $62,166 - $72,742	1,560 Added 1.52%	103,879 $4.26 Million
Q1 2021 May 13, 2021	BUY	$42.34 - $52.82 $2.9 Million - $3.62 Million	68,469 Added 202.27%	102,319 $4.46 Million
Q4 2020 Feb 10, 2021	BUY	$36.12 - $50.05 $1.22 Million - $1.69 Million	33,850 New	33,850 $1.69 Million

Others Institutions Holding RPRX

# of Institutions

536

Shares Held

304M

Call Options Held

1.34M

Put Options Held

252K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $17.1B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account